{"product_id":"asn-kidney-transplantation-2021","title":"ASN Kidney Transplantation 2021 Update","description":"\u003cdiv class=\"prod-format\"\u003e\n\u003ch1 class=\"product-title product_title entry-title\"\u003eASN Kidney Transplantation 2021 Update\u003c\/h1\u003e\n\u003cstrong\u003eContent \u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAcute Rejection and Banff Classification\u003c\/li\u003e\n\u003cli\u003eBasic Immunology of Transplantation for Clinicians\u003c\/li\u003e\n\u003cli\u003eCOVID-19 in Kidney Transplant Patients\u003c\/li\u003e\n\u003cli\u003eDisparities in Access to Kidney Transplantation\u003c\/li\u003e\n\u003cli\u003eEvaluation of Living Kidney Donors, Including Medically Complex Patients\u003c\/li\u003e\n\u003cli\u003eImmunological Assessment and HLA and Epitope Matching\u003c\/li\u003e\n\u003cli\u003eImmunosuppressive Regimens and Outcomes\u003c\/li\u003e\n\u003cli\u003eMedical Evaluation of Potential Recipients\u003c\/li\u003e\n\u003cli\u003eOptimizing Deceased Donor Allocation\u003c\/li\u003e\n\u003cli\u003eOutcomes, Risk Assessment, and Ethical Considerations for Living Donors\u003c\/li\u003e\n\u003cli\u003ePharmacology of Immunosuppressive Agents, Drug-Drug Interactions, and Adverse Effects\u003c\/li\u003e\n\u003cli\u003ePolyomaviruses and Cytomegalovirus\u003c\/li\u003e\n\u003cli\u003ePost-Transplant Malignancies\u003c\/li\u003e\n\u003cli\u003eRecurrent Glomerular Disease\u003c\/li\u003e\n\u003cli\u003eWhat’s in the Pipeline Future Developments in Transplantation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954325459042,"sku":"MED-AMB01457","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/ASN-Kidney-Transplantation-2021-Update.jpg?v=1779371382","url":"https:\/\/meducourse.com\/products\/asn-kidney-transplantation-2021","provider":"Meducourse","version":"1.0","type":"link"}